Orthobiologics

SpinalCyte was issued Australian Patent No. 2015202319, “Methods and Compositions for Repair of Cartilage Using an In Vivo Bioreactor.”...

Bone Therapeutics reports positive interim efficacy results and early conclusion of the Phase I/IIA study of ALLOB® allogeneic bone cell therapy in...

Bone Solutions commenced U.S. launch of OsteoCrete®, the first magnesium-based bone void filler in the U.S. ...

Follow-up data from an IDE clinical trial of Cerapedics’ i-FACTOR™ bone graft indicated statistical superiority to autograft in ACDF....

MiMedx received permission to proceed with an Investigational New Drug Phase III clinical trial of AmnioFix® Injectable in the treatment...

Bioventus received FDA premarket approval for DUROLANE single-injection hyaluronic acid to treat pain associated with knee osteoarthritis....

Orthocell announced recruitment of the first patient in a clinical trial investigating Ortho-ATI® to treat rotator cuff tendinopathy....

Medtronic launched a long-term global clinical study to collect prospective data on INFUSE® bone graft in posterolateral and transforaminal lumbar...

Kuros Biosciences received FDA 510(k) clearance to market MagnetOs synthetic bone graft putty as an autograft extender in the posterolateral...

Regentis Biomaterials received CE Mark approval for a GelrinC biodegradable implant based on denatured human fibrinogen for the treatment of articular...